Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis

References

• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of viral hepatitis. 2004;11(2):97–107. doi:10.1046/j.1365-2893.2003.00487.x. PMID:14996343
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID:23245604
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiologic reviews. 2006;28:112–25. doi:10.1093/epirev/mxj009. PMID:16754644
   PubMed Web of Science ®Google Scholar
• Wang FZ, Zhang GM, Shen LP, Zheng H, Wang F, Miao N, et al. Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1–29 years in different epidemic regions of China in 1992 and 2014. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2017;51(6):462–8. PMID:28592086
   PubMedGoogle Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerging infectious diseases. 2017;23(5):765–72. doi:10.3201/eid2305.161477. PMID:28418296
   PubMed Web of Science ®Google Scholar
• Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. Journal of medical virology. 2006;78(2):169–77. doi:10.1002/jmv.20524. PMID:16372285
   PubMed Web of Science ®Google Scholar
• Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: A review. Communicable disease and public health. 2003;6(2):106–12. PMID:12889288
   PubMedGoogle Scholar
• Newport MJ, Goetghebuer T, Weiss HA, Whittle H, Siegrist CA, Marchant A, et al. Genetic regulation of immune responses to vaccines in early life. Genes and immunity. 2004;5(2):122–9. doi:10.1038/sj.gene.6364051. PMID:14737096
   PubMed Web of Science ®Google Scholar
• Hohler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet. 2002;360(9338):991–5. doi:10.1016/S0140-6736(02)11083-X. PMID:12383669
   PubMed Web of Science ®Google Scholar
• Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Scientific reports. 2016;6:27251. doi:10.1038/srep27251. PMID:27324884
   PubMed Web of Science ®Google Scholar
• Boland GJ, van Bommel T, Rulos-van den Berg A, van den Berg JP, van Loon AM, van Hattum J. The efficacy of a two-dose hepatitis B vaccination scheme. Advances in experimental medicine and biology. 2003;531:185–90. doi:10.1007/978-1-4615-0059-9_14. PMID:12916790
   PubMed Web of Science ®Google Scholar
• Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology. 2005;41(6):1383–90. doi:10.1002/hep.20716. PMID:15915462
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu P, Zhu D, Zhang S, Bi Y, Hu Y, et al. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine. 2012;30(39):5708–13. doi:10.1016/j.vaccine.2012.07.010. PMID:22824342
   PubMed Web of Science ®Google Scholar
• Pan L, Zhang W, Liang Z, Wu X, Zhu X, Li J, et al. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. Journal of medical virology. 2012;84(1):26–33. doi:10.1002/jmv.22251. PMID:22052597
   PubMed Web of Science ®Google Scholar
• Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scandinavian journal of immunology. 2002;55(3):311–4. doi:10.1046/j.1365-3083.2002.01057.x. PMID:11940238
   PubMed Web of Science ®Google Scholar
• Valats JC, Tuaillon E, Funakoshi N, Hoa D, Brabet MC, Bollore K, et al. Investigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccination. Vaccine. 2010;28(39):6411–6. doi:10.1016/j.vaccine.2010.07.058. PMID:20682363
   PubMed Web of Science ®Google Scholar
• Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, et al. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology. 2004;326(1):20–28. doi:10.1016/j.virol.2004.04.042. PMID:15262491
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature immunology. 2009;10(1):116–25. doi:10.1038/ni.1688. PMID:19029902
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of vaccination for seasonal influenza in humans. Nature immunology. 2011;12(8):786–95. doi:10.1038/ni.2067. PMID:21743478
   PubMed Web of Science ®Google Scholar
• Pan HX, Zeng Y, Song XF, Zhang YJ, Xu K, Liang ZL, et al. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Vaccine. 2014;32(29):3706–12. doi:10.1016/j.vaccine.2014.02.094. PMID:24681228
   PubMed Web of Science ®Google Scholar
• Cardell K, Akerlind B, Sallberg M, Fryden A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. The Journal of infectious diseases. 2008;198(3):299–304. doi:10.1086/589722. PMID:18544037
   PubMed Web of Science ®Google Scholar
• Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004;39(4):978–88. doi:10.1002/hep.20142. PMID:15057902
   PubMed Web of Science ®Google Scholar
• Lin YJ, Lan YC, Huang YC, Lin TH, Huang SM, Lai CC, et al. Effects of cytokine and cytokine receptor gene variation on high anti-HB titers: following up on Taiwan's neonatal hepatitis B immunization program. Clinica chimica acta; international journal of clinical chemistry. 2012;413(15-16):1194–8. doi:10.1016/j.cca.2012.03.004. PMID:22484276
   PubMed Web of Science ®Google Scholar
• Yoon JH, Shin S, In J, Chang JY, Song EY, Roh EY. Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants. Vaccine. 2014;32(43):5638–44. doi:10.1016/j.vaccine.2014.08.007. PMID:25148772
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nature immunology. 2014;15(2):195–204. doi:10.1038/ni.2789. PMID:24336226
   PubMed Web of Science ®Google Scholar
• Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. Journal of immunology. 1992;148(2):532–7.
   PubMed Web of Science ®Google Scholar
• Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nature reviews Immunology. 2006;6(6):447–56. doi:10.1038/nri1860. PMID:16724099
   PubMed Web of Science ®Google Scholar
• Wang F, Qiao L, Lv X, Trivett A, Yang R, Oppenheim JJ, et al. Alarmin human alpha defensin HNP1 activates plasmacytoid dendritic cells by triggering NF-kappaB and IRF1 signaling pathways. Cytokine. 2016;83:53–60. doi:10.1016/j.cyto.2016.03.015. PMID:27031443
   PubMed Web of Science ®Google Scholar
• Rodriguez-Garcia M, Oliva H, Climent N, Escribese MM, Garcia F, Moran TM, et al. Impact of alpha-defensins1-3 on the maturation and differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual effects. Clinical immunology. 2009;131(3):374–84. doi:10.1016/j.clim.2009.01.012. PMID:19237318
   PubMed Web of Science ®Google Scholar
• Trulson A, Bystrom J, Engstrom A, Larsson R, Venge P. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2007;37(2):208–18. doi:10.1111/j.1365-2222.2007.02644.x. PMID:17250693
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Hogan SP. The eosinophil. Annual review of immunology. 2006;24:147–74. doi:10.1146/annurev.immunol.24.021605.090720. PMID:16551246
   PubMed Web of Science ®Google Scholar
• Dejonckheere E, Vandenbroucke RE, Libert C. Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression. Cytokine & growth factor reviews. 2011;22(2):73–81. doi:10.1016/j.cytogfr.2011.02.002.
   PubMed Web of Science ®Google Scholar
• Shen F, Wu M, Ross JF, Miller D, Ratnam M. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity. Biochemistry. 1995;34(16):5660–5. doi:10.1021/bi00016a042. PMID:7727426
   PubMed Web of Science ®Google Scholar
• Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P, et al. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Human molecular genetics. 2009;18(23):4677–87. doi:10.1093/hmg/ddp428. PMID:19744961
   PubMed Web of Science ®Google Scholar
• Grimm M, Schmitt S, Teriete P, Biegner T, Stenzl A, Hennenlotter J, et al. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC cancer. 2013;13:569. doi:10.1186/1471-2407-13-569. PMID:24304513
   PubMed Web of Science ®Google Scholar
• Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717–23. PMID:23051753
   PubMed Web of Science ®Google Scholar
• Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2012;90(3):252–68. doi:10.1139/o11-056. PMID:22136726
   PubMed Web of Science ®Google Scholar
• Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2006;84(3):303–11. doi:10.1139/o06-058. PMID:16936801
   PubMed Web of Science ®Google Scholar
• Cui D, Li L, Lou H, Sun H, Ngai SM, Shao G, et al. The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene. 2014;33(17):2225–35. doi:10.1038/onc.2013.170. PMID:23728348
   PubMed Web of Science ®Google Scholar
• Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science. 2014;344(6181):310–3. doi:10.1126/science.1251456. PMID:24744378
   PubMed Web of Science ®Google Scholar
• Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(25):15047–52. doi:10.1073/pnas.2536517100. PMID:14657353
   PubMed Web of Science ®Google Scholar
• Diveu C, McGeachy MJ, Boniface K, Stumhofer JS, Sathe M, Joyce-Shaikh B, et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. Journal of immunology. 2009;182(9):5748–56. doi:10.4049/jimmunol.0801162.
   PubMed Web of Science ®Google Scholar
• Egawa T, Kawabata K, Kawamoto H, Amada K, Okamoto R, Fujii N, et al. The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor. Immunity. 2001;15(2):323–34. doi:10.1016/S1074-7613(01)00185-6. PMID:11520466
   PubMed Web of Science ®Google Scholar
• Ferrari D, Gulinelli S, Salvestrini V, Lucchetti G, Zini R, Manfredini R, et al. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. Experimental hematology. 2011;39(3):360–374, 374 e361–365. doi:10.1016/j.exphem.2010.12.001.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–s8. doi:10.1006/meth.2001.1262. PMID:11846609
   PubMed Web of Science ®Google Scholar